Walking with knee OA

"Wear and tear" is the wrong model. Cartilage is load-adapted tissue, not brake pads: walking delivers moderate cyclic load — the dose region where cartilage is maintained rather than degraded — while disuse demonstrably thins it. The fear that every step spends down a fixed cartilage budget is the single most damaging misconception in this section, and the cohort data run directly against it.

Walking with OA that already exists

The Osteoarthritis Initiative followed 1,212 adults over 50 with knee OA for four years. Those who walked for exercise had less new frequent knee pain (OR 0.6, 95% CI 0.4–0.8) and less medial joint-space-narrowing progression (OR 0.8, 95% CI 0.6–1.0) than non-walkers. In a separate cohort of 1,788 people with or at risk of knee OA wearing accelerometers, each additional 1,000 steps per day predicted a 16–18% lower risk of functional limitation two years later; walking at least 6,000 steps a day best separated the people who stayed functional.

The running stress test

If walking wore out knees, running should wear them out faster. It doesn't appear to. A meta-analysis spanning 125,810 people found hip or knee OA in 3.5% of recreational runners versus 10.2% of sedentary controls; only high-volume competitive running trended higher (OR 1.34, with a confidence interval crossing 1). A second meta-analysis (n=114,829) found no overall excess knee OA among runners — and lower odds of knee surgery for OA (OR 0.46). An 18-year prospective cohort found long-distance runners developed no more radiographic knee OA than controls (20% vs 32%, p=0.25), with severe OA numerically rarer in runners.

Why this isn't "strong"

Every study above is observational. People who feel better walk more — reverse causation — and runners self-select for robust knees; no cohort fully escapes this, which is why the tier stays promising despite six-figure sample sizes. The structural finding in the OAI analysis was borderline, with a confidence interval touching 1.0. The reassurance also has a dose edge: competitive and elite running shows higher OA prevalence (13.3% vs 10.2%), so the all-clear applies to moderate doses. And none of these cohorts included people with large cartilage defects after repair — post-op walking progression follows surgical protocols, not this entry.

Practical dosing

The functional-benefit threshold in the OA cohorts sits around 6,000 steps per day, with additional benefit per extra 1,000 steps. For painful knees, build volume gradually under the pain-monitoring rules in the load-management entry — pain up to about 5/10 that settles by the next morning — and manage flares by adjusting dose rather than stopping.

Open questions

A pragmatic RCT of structured walking in knee OA with structural endpoints has never been run. Step thresholds for post-cartilage-repair patients are unknown, and whether the competitive-running signal reflects dose or selection remains unresolved.